United States Pharmaceuticals and Healthcare Report Q1 2015

Business Monitor International
December 31, 2014
118 Pages - SKU: BMI5432550
Countries covered: United States

United States Pharmaceuticals and Healthcare Report Q1 2015

BMI View: In the face of increasing product launches within highly-competitive therapeutic areas such asdiabetes care in the US, payers are becoming ever more confident in leveraging their purchasing powerover pharmaceutical companies. With few differentiating factors between competing products, pharmacybenefit managers and health insurers are in a position to secure better deals for themselves.

Headline Expenditure Projections

Pharmaceuticals: USD347.2bn in 2013 to USD354.2bn in 2014; 2.0% growth. Forecast revisedupwards from Q414.

Healthcare: USD2,918bn in 2013 to USD3,099bn in 2014; +6.2% growth. Forecast revised upwardsfrom Q414.



More Manufacturing, Packaging & Detailing reports by Business Monitor International

Namibia Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Namibia Pharmaceuticals and Healthcare Report Q1 2015BMI View: Recent comments by the public relations officer of the Ministry of Health and Social Services,Ester Paulus, that ...
Moldova Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Moldova Pharmaceuticals and Healthcare Report Q1 2015BMI View: The Moldovan pharmaceutical market presents limited opportunities for investors in the shortterm, but with the country opening ...
Ghana Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Ghana Pharmaceuticals and Healthcare Report Q1 2015BMI View: We anticipate that the continuing roll-out of biometric registration and expansion of thecommunity-based health planning and services ...
Central America Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Central America Pharmaceuticals and Healthcare Report Q1 2015BMI View: Central America will continue to offer revenue-generating opportunities for multinationalpharmaceutical companies. An ageing population, favourable tax ...
See all reports like this >>

More United States Manufacturing, Packaging & Detailing reports

Chemicals Manufacturing, Including Basic, Specialty, Petrochemicals, Pharmaceuticals, Soaps and Paints, Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325000 by Plunkett Research, Ltd.
Chemicals Manufacturing, Including Basic, Specialty, Petrochemicals, Pharmaceuticals, Soaps and Paints, Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325000Vital ...
Pharmaceutical Manufacturing by First Research, Inc.
Pharmaceutical ManufacturingBrief Excerpt from Industry Overview Chapter:Companies in this industry manufacture and process pharmaceutical products. Major companies include Bristol-Myers Squibb, Eli Lilly, Johnson & Johnson, ...
Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325414 by Plunkett Research, Ltd.
Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325414Vital industry-specific data including ...
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 by Plunkett Research, Ltd.
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400Vital industry-specific data including metrics, benchmarks, ...
See all reports like this >>

More United States reports

The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United States by Icon Group International, Inc.
The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United StatesThis econometric study covers the latent demand outlook for collagen and (hyaluronic ...
The 2013-2018 Outlook for Relish in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for relish across the states and cities of the United States. Latent demand (in millions of U.S. ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!